Figure 3 summarizes the effect of particular small-molecule protein kinases and their inhibitors on the PAH microenvironment, including such molecular hallmarks as inflammation, apoptosis, proliferation, or mitochondrial function. Here, WEE1 is linked to pulmonary arterial hypertension.